Meta-analysis on risk stratification of malignant ventricular tachyarrhythmic events in arrhythmogenic right ventricular cardiomyopathy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a cardiomyopathy characterized by predominant right ventricular fibro-fatty replacement, right ventricular dysfunction and ventricular arrhythmias. It is a rare but important cause of sudden cardiac death in children and young adults. A meta-analysis on risk stratification of major ventricular tachyarrhythmic events indicating the need for implantable cardioverter defibrillator therapy in ARVC was performed. Methods: The pubmed database was searched from its inception to May 2015. Of the 433 citations identified, 12 were included in this meta-analysis. Data regarding major ventricular tachyarrhythmic events were retrieved in 817 subjects from the studies. For the variables, a combined odds ratio (OR) was calculated using a fixed-effects meta-analysis. Results: Extensive right ventricular dysfunction (OR, 2.44), ventricular late potential (OR, 1.66), inducible ventricular tachyarrhythmia during electrophysiology study (OR, 3.67), non-sustained ventricular tachycardia (OR, 3.78), and history of fatal event/sustained VT (OR, 5.66) identified as significant risk factors (p<0.0001). Conclusion: This meta-analysis shows that extensive right ventricular dysfunction, ventricular late potential, inducible ventricular tachyarrhythmia during electrophysiological study, non-sustained ventricular tachycardia, and history of sustained ventricular tachycardia/fibrillation are consistently reported risk factors of major ventricular tachyarrhythmic events indicating implantable cardioverter defibrillator therapy in patients with ARVC
Abstract
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a cardiomyopathy characterized by predominant right ventricular fibro-fatty replacement, right ventricular dysfunction and ventricular arrhythmias. It is a rare but important cause of sudden cardiac death in children and young adults. A meta-analysis on risk stratification of major ventricular tachyarrhythmic events indicating the need for implantable cardioverter defibrillator therapy in ARVC was performed. Methods: The pubmed database was searched from its inception to May 2015. Of the 433 citations identified, 12 were included in this meta-analysis. Data regarding major ventricular tachyarrhythmic events were retrieved in 817 subjects from the studies. For the variables, a combined odds ratio (OR) was calculated using a fixed-effects meta-analysis. Results: Extensive right ventricular dysfunction (OR, 2.44), ventricular late potential (OR, 1.66), inducible ventricular tachyarrhythmia during electrophysiology study (OR, 3.67), non-sustained ventricular tachycardia (OR, 3.78), and history of fatal event/sustained VT (OR, 5.66) identified as significant risk factors (p<0.0001). Conclusion: This meta-analysis shows that extensive right ventricular dysfunction, ventricular late potential, inducible ventricular tachyarrhythmia during electrophysiological study, non-sustained ventricular tachycardia, and history of sustained ventricular tachycardia/fibrillation are consistently reported risk factors of major ventricular tachyarrhythmic events indicating implantable cardioverter defibrillator therapy in patients with ARVC
참고문헌 (30)
- Thiene G, "Right ventricular cardiomyopathy and sudden death in young people", N Engl J Med, 318, pp.129~133 (1988)
- Corrado D, "Does sports activity enhance the risk of sudden death in adolescents and young adults?", J Am Coll Cardiol, 42, pp.1959~1963 (2003)
- Holst AG, "Incidence and etiology of sports-related sudden cardiac death in Denmark--implications for preparticipation screening", Heart Rhythm, 7, pp.1365~1371 (2010)
- Corrado D, "Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy", dysplasia, 2003, pp.108, 3084~3091
- Wichter T, "Implantable cardioverter", defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60patients, 2004, pp.109, 1503~1508
- Piccini JP, "Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia", Heart Rhythm, 2, pp.1188~1194 (2005)
- Pezawas T, "Ventricular tachycardia in arrhythmogenic right ventricular dysplasia", cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up, 2006, pp.107, 360~368
- Corrado D, "Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy", dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia, 2010, pp.122, 1144~1152
- Bhonsale A, "Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia", cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention, 2011, pp.58, 1485~1496
- Schuler PK, "Predictors of appropriate ICD therapy in patients with arrhythmogenic right ventricular cardiomyopathy:long term experience of a tertiary care center", PLoS One, 7, pp.e39584~ (2012)
- Battipaglia I, "Association of heart rate variability with arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy", dysplasia, 2012, pp.76, 618~623
- Santangeli P, "Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study", Heart Rhythm, 9, pp.1200~1206 (2012)
- Canpolat U, "Fragmented QRS complex predicts the arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy", dysplasia, 2013, pp.24, 1260~1266
- Link MS, "Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment", J Am Coll Cardiol, 64, pp.119~125 (2014)
- Ruiz-Salas A, "Longterm prognosis of patients with arrhythmogenic right ventricular cardiomyopathy and implantable defibrillator", Int J Cardiol, 174, pp.794~796 (2014)
- Zipes DP, "Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Executive summary", Rev Esp Cardiol, 59, pp.1328~ (2006)
- Chung FP, "Seasonal variation in the frequency of sudden cardiac death and ventricular tachyarrhythmia in patients with arrhythmogenic right ventricular dysplasia", cardiomyopathy: the effect of meteorological factors, 2013, pp.10, 1859~1866
- Roguin A, "Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia", cardiomyopathy, 2004, pp.43, 1843~1852
- Marcus FI, "Right ventricular dysplasia: a report of 24 adult cases", Circulation, 65, pp.384~398 (1982)
- Sen-Chowdhry S, "Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management", Am J Med, 117, pp.685~695 (2004)
- Sen-Chowdhry S, "Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype", J Am Coll Cardiol, 48, pp.2132~2140 (2006)
- Gemayel C, "Arrhythmogenic right ventricular cardiomyopathy", J Am Coll Cardiol, 38, pp.1773~1781 (2001)
- Blomström-Lundqvist C, "Followup by repeated signal-averaged surface QRS in patients with the syndrome of arrhythmogenic right ventricular dysplasia", Eur Heart J, 10(Suppl D), pp.54~60 (1989)
- Turrini P, "Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy", Am J Cardiol, 83, pp.1214~1219 (1999)
- Migliore F, "Prevalence of cardiomyopathy in Italian asymptomatic children with electrocardiographic T-wave inversion at preparticipation screening", Circulation, 125, pp.529~538 (2012)
- Wichter T, "Implantable cardioverter", defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60patients, 2004, pp.109, 1503~1508
- Basso C, "Arrhythmogenic right ventricular cardiomyopathy", Circ Arrhythm Electrophysiol, 5, pp.1233~1246 (2012)
- Hulot JS, "Natural history and risk stratification of arrhythmogenic right ventricular dysplasia", cardiomyopathy, 2004, pp.110, 1879~1884
- Dalal D, "Arrhythmogenic right ventricular dysplasia: a United States experience", Circulation, 112, pp.3823~3832 (2005)
- Marcus FI, "Long-term follow-up in patients with arrhythmogenic right ventricular disease", Eur Heart J, 10(Suppl D), pp.68~73 (1989)